Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZK245186 in Atopic Dermatitis
NCT01228513Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2010
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of mapracorat in atopic dermatitis (AD), sponsored by Bayer. Started Nov 2010; status: completed.
02
Drugs
mapracorat
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01228513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228513.